We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

RNAi-based Drug Shows Promise as Treatment for Chronic Hepatitis B

News   Nov 22, 2017 | Original story from Texas Biomedical Research Institute

 
RNAi-based Drug Shows Promise as Treatment for Chronic Hepatitis B
 
 
 

RELATED ARTICLES

Patient-specific Organoid Models Appendix Cancer Treatment

News

Patient-specific tumor ‘organoid’ models have been developed, to identify the most effective treatment for each tumor.

READ MORE

Prostate Cancer Scoring Method may Underestimate Mortality Risk in Black Men

News

Black men diagnosed with prostate cancer classified as low risk may actually have a more aggressive form of the disease that is more likely to be fatal than in nonblack men placed in the same prognostic category, a new study suggests.

READ MORE

Alzheimer's Trafficking Defect Corrected in Rodents

News

UT Southwestern researchers have succeeded in neutralizing what they believe is a primary factor in late-onset Alzheimer’s disease, opening the door to development of a drug that could be administered before age 40, and taken for life, to potentially prevent the disease in 50 to 80 percent of at-risk adults.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE